Unlock Exclusive Discounts & Flash Sales! Click Here to Join the Deals on Every Wednesday!
Alogliptin decreases the incretin glucose dependent insulinotropic polypeptide (GIP) and glucagon like peptide (GLP-2). increases the plasma incretin concentration, which can controls the glucose levels in the blood. GIP and GLP-2 are stimulating the glucose dependent pancreatic beta cells. It inhibits the activity of GIP and GLP-2.